Drug Development Archives

Publication

Simcyp 群体模拟器中 PBPK 建模复合文件开发指南

The Simcyp Simulator is a software platform for population physiologically-based pharmacokinetic (PBPK) modeling and simulation.…

Certara2024 年 2 月 23 日

Publication

Interlaboratory Variability in the Madin–Darby Canine Kidney Cell Proteome

Madin–Darby canine kidney (MDCK) cells are widely used to study epithelial cell functionality. Their low…

Certara2023 年 6 月 28 日

Conference

American College of Toxicology 2025 Annual Meeting

– – Booth

Certara2023 年 5 月 24 日

Conference

ACoP 2025

Certara2023 年 5 月 24 日

Conference

ACCP 年度会议

– – Booth

Certara2022 年 7 月 15 日

Publication

Blueprint for pandemic response: Focus on translational medicine, clinical pharmacology and pharmacometrics

Perhaps the most important lesson learned from the COVID‐19 pandemic is that of preparedness. Enhanced…

Certara2021 年 5 月 11 日

On-Demand Webinar

纯洁是一种美德：杂质报告的实用指南

Many pharmaceutical companies struggle with characterizing drug substance (DS) and drug product (DP) impurities and…

Certara2021 年 3 月 23 日

White Paper

利用 QSP 优化免疫肿瘤药物发现与开发

A Quantitative Systems Pharmacology (QSP) approach for developing combination immune-oncology therapies can be used to…

Certara2019 年 6 月 19 日

Blog

7 Things to Know About the China Pharmaceutical Industry

China is the second largest pharmaceutical market in the world. Demand is likely to increase…

Certara2018 年 10 月 16 日

Brochure

Pharmacokinetic/ Toxicokinetic Services

As your partner for drug development and regulatory strategy, Certara has expanded its services to…

Certara2018 年 5 月 18 日

药物开发

Simcyp 群体模拟器中 PBPK 建模复合文件开发指南

Interlaboratory Variability in the Madin–Darby Canine Kidney Cell Proteome

American College of Toxicology 2025 Annual Meeting

ACoP 2025

ACCP 年度会议

Blueprint for pandemic response: Focus on translational medicine, clinical pharmacology and pharmacometrics

纯洁是一种美德：杂质报告的实用指南

利用 QSP 优化免疫肿瘤药物发现与开发

7 Things to Know About the China Pharmaceutical Industry

Pharmacokinetic/ Toxicokinetic Services

订阅时事通讯

快捷链接

解决方案

联系我们